The five-year trial saw patients who received a single injection of Lumevoq sustaining clinical recovery in a rare condition ...
An innovative organoid model mirrors the pancreas' complexity, generating all three key cell types to explore development and possible regeneration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback